Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2018 · 10-Q
Revenue$3.39M$3.39M+97.7% vs Q3 2017 Net Income-$3.50M-$3.50MN/M vs Q3 2017 EPS Diluted-$0.02-$0.02N/M vs Q3 2017 Gross Profit$1,869,799+60.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,728,918N/M Free Cash Flowderived-$3,324,746N/M Margins · derivedGross margin55.1%−12.9 pt vs Q3 2017
Operating margin-16.2%−32.9 pt vs Q3 2017
Net margin-103.3%−80.4 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end